Avanos Medical (AVNS) Operating Expenses (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Operating Expenses data on file, last reported at $82.9 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 2.22% year-over-year to $82.9 million; the trailing twelve-month figure through Mar 2026 stood at $340.7 million (up 1.64% YoY), and the FY2025 full-year result was $338.9 million, down 1.68% from the prior year.
• Operating Expenses fell to $82.9 million in Q1 2026, from $84.9 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $99.8 million in Q2 2023 to a low of $81.1 million in Q1 2025.
• A 5-year average of $87.6 million and a median of $85.4 million in 2022 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses grew 29.95% in 2022 and dropped 12.63% in 2024, its largest moves.
• Tracing AVNS's Operating Expenses over 5 years: stood at $85.9 million in 2022, then dropped by 5.36% to $81.3 million in 2023, then rose by 5.04% to $85.4 million in 2024, then fell by 0.59% to $84.9 million in 2025, then slipped by 2.36% to $82.9 million in 2026.
• Business Quant data shows AVNS's Operating Expenses at $82.9 million in Q1 2026, $84.9 million in Q4 2025, and $83.6 million in Q3 2025.